Anna Garratt

746 total citations · 1 hit paper
5 papers, 363 citations indexed

About

Anna Garratt is a scholar working on Infectious Diseases, Neurology and General Health Professions. According to data from OpenAlex, Anna Garratt has authored 5 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 2 papers in Neurology and 1 paper in General Health Professions. Recurrent topics in Anna Garratt's work include SARS-CoV-2 and COVID-19 Research (2 papers), COVID-19 Clinical Research Studies (2 papers) and Long-Term Effects of COVID-19 (2 papers). Anna Garratt is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (2 papers), COVID-19 Clinical Research Studies (2 papers) and Long-Term Effects of COVID-19 (2 papers). Anna Garratt collaborates with scholars based in United Kingdom, United States and Iran. Anna Garratt's co-authors include Jonathan Guo, Andrew Hill, Andrew Hill, Jacob Levi, Bryony Simmons, Hannah Wentzel, Shahin Merat, Anahita Sadeghı, Ambar Qavi and Rasoul Aliannejad and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Antimicrobial Chemotherapy and Journal of Cystic Fibrosis.

In The Last Decade

Anna Garratt

5 papers receiving 358 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Worldwide rates of diagnosis and effective treatment for cystic fibrosis

2022 192 citations Jonathan Guo, Anna Garratt et al. Journal of Cystic Fibrosis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Garratt United Kingdom	4	158	147	48	46	35	5	363
Wang Xf China	8	37 0.2×	139 0.9×	50 1.0×	49 1.1×	42 1.2×	39	299
Yuchong Li China	7	41 0.3×	187 1.3×	33 0.7×	42 0.9×	33 0.9×	14	308
Javid Azadbakht Iran	7	25 0.2×	128 0.9×	58 1.2×	41 0.9×	23 0.7×	28	292
Ching‐Lung Liu Taiwan	8	50 0.3×	196 1.3×	46 1.0×	18 0.4×	54 1.5×	21	330
Khalil Ansarin Iran	7	36 0.2×	137 0.9×	46 1.0×	42 0.9×	14 0.4×	12	241
Lorenzo Bertolino Italy	9	29 0.2×	205 1.4×	95 2.0×	45 1.0×	99 2.8×	26	350
Andrew Hill United Kingdom	9	173 1.1×	55 0.4×	10 0.2×	44 1.0×	112 3.2×	25	488
Volker Thieme Germany	5	29 0.2×	140 1.0×	61 1.3×	24 0.5×	30 0.9×	11	270
Kwame Dapaah-Afriyie United States	9	52 0.3×	198 1.3×	101 2.1×	36 0.8×	39 1.1×	25	309
Abhijeet Singh India	10	39 0.2×	223 1.5×	10 0.2×	22 0.5×	105 3.0×	26	428

Countries citing papers authored by Anna Garratt

Since Specialization

Citations

This map shows the geographic impact of Anna Garratt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Garratt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Garratt more than expected).

Fields of papers citing papers by Anna Garratt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Garratt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Garratt. The network helps show where Anna Garratt may publish in the future.

Co-authorship network of co-authors of Anna Garratt

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Garratt. A scholar is included among the top collaborators of Anna Garratt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Garratt. Anna Garratt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Guo, Jonathan, Anna Garratt, & Andrew Hill. (2022). Worldwide rates of diagnosis and effective treatment for cystic fibrosis. Journal of Cystic Fibrosis. 21(3). 456–462. 192 indexed citations breakdown →

2.

Garratt, Anna, et al.. (2021). Quality improvement in action. British Journal of Midwifery. 29(10). 546–548. 1 indexed citations

3.

Sadeghı, Anahita, Ali Asgari, Alireza Norouzi, et al.. (2020). Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial. Journal of Antimicrobial Chemotherapy. 75(11). 3379–3385. 84 indexed citations

4.

Moradi, Siavash, Farhang Babamahmoodi, Ahmad Alikhani, et al.. (2020). Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trial. Journal of Antimicrobial Chemotherapy. 75(11). 3373–3378. 66 indexed citations

5.

Pozniak, Anton, Jacob Levi, Polly Clayden, et al.. (2019). Analysis of Pharmacovigilance Databases for Dolutegravir Safety in Pregnancy. Clinical Infectious Diseases. 70(12). 2599–2606. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact